Page last updated: 2024-10-21

3,4-methylenedioxyamphetamine and Multiple Organ Failure

3,4-methylenedioxyamphetamine has been researched along with Multiple Organ Failure in 1 studies

3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.

Multiple Organ Failure: A progressive condition usually characterized by combined failure of several organs such as the lungs, liver, kidney, along with some clotting mechanisms, usually postinjury or postoperative.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hall, AP1

Other Studies

1 other study available for 3,4-methylenedioxyamphetamine and Multiple Organ Failure

ArticleYear
Ecstasy: creatinine kinase.
    Anaesthesia and intensive care, 1997, Volume: 25, Issue:5

    Topics: 3,4-Methylenedioxyamphetamine; Creatine Kinase; Dantrolene; Designer Drugs; Fever; Humans; Multiple

1997